Table 1 Patient antiemetic use characteristics
Variable | Total | Antiemetic use | P-value | |
|---|---|---|---|---|
No | Yes | |||
Patient number (N) | 967 | 867 (89.7%) | 100 (10.3%) | |
Baseline characteristics | ||||
Age | 53.70 ± 15.57 | 54.49 ± 15.27 | 46.87 ± 16.55 | < 0.001 |
Gender | 0.002 | |||
Male | 307 (31.7%) | 289 (33.3%) | 18 (18.0%) | |
Female | 660 (68.3%) | 578 (66.7%) | 82 (82.0%) | |
Kidney function | ||||
eGFR | 84.62 ± 32.22 | 83.61 ± 28.48 | 93.38 ± 54.27 | 0.079 |
Body measurement | ||||
Waist/Hip | 0.91 ± 0.08 | 0.91 ± 0.08 | 0.90 ± 0.07 | 0.460 |
BMI | 26.57 ± 6.59 | 26.08 ± 6.16 | 30.81 ± 8.42 | < 0.001 |
Other data | ||||
Diabetes | 198 (20.5%) | 173 (20.0%) | 25 (25.0%) | 0.236 |
Smoking | 230 (23.8%) | 221 (25.5%) | 9 (9.0%) | < 0.001 |
Anesthesia time | 186.71 ± 90.89 | 187.87 ± 92.51 | 176.61 ± 75.07 | 0.241 |
Surgery method | < 0.001 | |||
Upper abdominal | 129 (13.3%) | 125 (14.4%) | 4 (4.0%) | |
Lower abdominal | 89 (9.2%) | 85 (9.8%) | 4 (4.0%) | |
Laparoscopic surgery | 210 (21.7%) | 157 (18.1%) | 53 (53.0%) | |
VAT | 148 (15.3%) | 130 (15.0%) | 18 (18.0%) | |
Other a | 391 (40.4%) | 370 (42.7%) | 21 (21.0%) | |
Pain | ||||
NRS rest | 2.33 ± 1.39 | 2.32 ± 1.40 | 2.41 ± 1.27 | 0.573 |
NRS move | 4.62 ± 1.73 | 4.64 ± 1.75 | 4.51 ± 1.51 | 0.465 |
NRS cough | 5.48 ± 1.82 | 5.51 ± 1.85 | 5.24 ± 1.52 | 0.096 |
Outcome information | ||||
Bad sleep | 532 (55.0%) | 459 (52.9%) | 73 (73.0%) | < 0.001 |
Bad vitality | 172 (17.8%) | 141 (16.3%) | 31 (31.0%) | < 0.001 |
Bad sleep and vitality | 132 (13.7%) | 104 (12.0%) | 28 (28.0%) | < 0.001 |
PONV Score | ||||
RINVR | 4.83 ± 7.57 | 3.34 ± 6.04 | 17.72 ± 7.26 | < 0.001 |
SPONVSS | 1.82 ± 3.02 | 1.22 ± 2.37 | 6.98 ± 3.15 | < 0.001 |